Scarica l'app Stockscreener
35.79
1.16%
-0.42
Pre-mercato:
36.49
0.70
+1.96%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$36.21
Aprire:
$36.6
Volume 24 ore:
591.60K
Relative Volume:
0.45
Capitalizzazione di mercato:
$2.35B
Reddito:
$796.00M
Utile/perdita netta:
$-136.49M
Rapporto P/E:
-17.12
EPS:
-2.09
Flusso di cassa netto:
$-64.24M
1 W Prestazione:
-3.40%
1M Prestazione:
+9.58%
6M Prestazione:
-22.31%
1 anno Prestazione:
+39.48%
Intervallo 1D:
$35.46
$36.70
Intervallo di 1 settimana:
$34.51
$37.80
Portata 52W:
$21.85
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Nome
Tandem Diabetes Care Inc
Settore
Industria
Telefono
858-366-6900
Indirizzo
12400 HIGH BLUFF DRIVE, San Diego, CA
Confronta TNDM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
35.79 | 2.35B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
113.02 | 196.03B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.65 | 140.97B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
362.80 | 138.31B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
85.25 | 109.31B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.04 | 41.90B | 6.60B | 4.16B | 490.10M | 6.93 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-10-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Aggiornamento | Stifel | Hold → Buy |
| 2023-08-04 | Downgrade | Citigroup | Buy → Neutral |
| 2023-05-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-08-09 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Iniziato | Wells Fargo | Overweight |
| 2020-07-31 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-18 | Reiterato | Raymond James | Outperform |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-06 | Iniziato | Raymond James | Outperform |
| 2020-02-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Iniziato | Guggenheim | Buy |
| 2019-10-04 | Aggiornamento | UBS | Neutral → Buy |
| 2019-05-17 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-13 | Iniziato | SVB Leerink | Outperform |
| 2019-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2019-03-05 | Reiterato | BofA/Merrill | Neutral |
| 2019-02-27 | Reiterato | Lake Street | Buy |
| 2018-11-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Reiterato | Dougherty & Company | Buy |
| 2018-09-26 | Reiterato | Piper Jaffray | Overweight |
Mostra tutto
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
JPMorgan Chase & Co. Acquires 113,355 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
UVA Center for Diabetes Technology, Tandem Diabetes Care to Research Fully Automated Insulin Delivery - Cville Right Now
Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain? - MSN
Advancing R&D of fully automated insulin delivery systems - Today's Medical Developments
automated insulin delivery systems - Today's Medical Developments
UVA Center for Diabetes to participate in research of auto insulin delivery - Augusta Free Press
When (TNDM) Moves Investors should Listen - Stock Traders Daily
Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech - Drug Delivery Business News
Tandem Diabetes Care, Inc. Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems - Marketscreener.com
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems - BioSpace
Tandem Diabetes Partners with UVA to Develop Next-Gen Automated Insulin Systems - StockTitan
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Principal Financial Group Inc. Sells 77,771 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
How the (TNDM) price action is used to our Advantage - Stock Traders Daily
Is Tandem Diabetes Care (NASDAQ:TNDM) Weighed On By Its Debt Load? - Simply Wall St
Insulin Pump Market Insights: Key Drivers, Competitive - openPR
Insulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica - GlobeNewswire Inc.
ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, I - GuruFocus.com
Insulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica - Yahoo Finance
Geode Capital Management LLC Has $64.72 Million Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
New partnerships, approvals pump prospects for insulin delivery devices - BioWorld Online
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada - MSN
Where are the Opportunities in (TNDM) - Stock Traders Daily
Barclays PLC Sells 174,647 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
State Street Corp Has $112.63 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care's SWOT analysis: stock outlook amid product innovation and market expansion - Investing.com Canada
TNDMTandem Diabetes Care, Inc. Latest Stock News & Market Updates - StockTitan
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada - GuruFocus.com
Forecasting the Global Insulin Delivery Device Market Growth at 9.28% CAGR till 2030, DelveInsight Report - EIN News
Tandem t: slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada - Marketscreener.com
La pompe à insuline Tandem t:slim X2 est désormais compatible avec la SGC Dexcom G7 au Canada - Eagle-Tribune
Fmr LLC Sells 328,206 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem's t:slim X2 Becomes First Insulin Pump in Canada to Integrate Both Dexcom G6 & G7 CGM Systems - StockTitan
Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound? - MSN
Point72 Asset Management L.P. Makes New Investment in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Holdings Reduced by Verition Fund Management LLC - MarketBeat
Janus Henderson Group PLC Has $38.74 Million Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives $54.25 Average Price Target from Analysts - MarketBeat
(TNDM) Investment Analysis and Advice - Stock Traders Daily
Reasons to Retain TNDM Stock in Your Portfolio for Now - MSN
MetLife Investment Management LLC Raises Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Charles Schwab Investment Management Inc. Acquires 18,874 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care (MEX:TNDM) 3-Year FCF Growth Rate : -117.40% (As of Sep. 2024) - GuruFocus.com
Jacobs Levy Equity Management Inc. Trims Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Morgan Stanley Upgrades Tandem Diabetes Care (TNDM) - MSN
Morgan Stanley raises Tandem Diabetes to Overweight, PT to $45 By Investing.com - Investing.com Canada
Morgan Stanley raises Tandem Diabetes to Overweight, PT to $45 - Investing.com
Tandem Diabetes Care Inc (TNDM) Shares Up 6.59% on Dec 2 - GuruFocus.com
Tandem Diabetes Care Inc Azioni (TNDM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):